Durham NC 血液癌症临床试验
16项针对 血液癌症的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
招募中观察性研究
- Duke University Medical Center, Durham
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
招募中3 期
- Duke Cancer Center ( Site 0028), Durham
- University of North Carolina at Chapel Hill ( Site 0040), Chapel Hill · 距离 10 英里
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
招募中观察性研究欢迎健康志愿者
- Durham VA Medical Center, Durham
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
招募中3 期
- Quetzal Site 27, Chapel Hill · 距离 10 英里
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
招募中3 期
- Duke University, Durham
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
招募中1/2 期
- UNC School of Medicine, Division of Hematology, Chapel Hill · 距离 10 英里
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
招募中3 期
- Duke University Medical Center, Durham
- University of North Carolina, Chapel Hill, Chapel Hill · 距离 10 英里
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics
招募中
- Lineberger Comphrehensive Cancer Center at University of North Carolina, Chapel Hill · 距离 10 英里
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)
招募中2 期
- Lineberger Cancer, Chapel Hill · 距离 10 英里
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment
招募中
- 2400 Pratt Street, Durham
Implementation of an Oral Chemotherapy Adherence Intervention
招募中
- UNC Chapel Hill, Chapel Hill · 距离 10 英里
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
招募中观察性研究
- Duke University Medical Center, Durham
- University of North Carolina at Chapel Hill, Chapel Hill · 距离 10 英里
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
招募中1 期
- University of North Carolina, Chapel Hill · 距离 10 英里
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Duke University Medical Center, Duke Cancer Center, Durham
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
招募中1 期
- Duke Blood Cancer Center, Durham
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
招募中早期 I 期
- Duke University Health System, Durham
其他城市的 血液癌症试验
- Houston, TX46 项研究
- New York City, NY26 项研究
- Boston, MA25 项研究
- Washington, DC19 项研究
- Seattle, WA18 项研究
- Baltimore, MD18 项研究
- Los Angeles, CA17 项研究
- Chicago, IL15 项研究
- Philadelphia, PA14 项研究
- Edison, NJ13 项研究
- Columbus, OH13 项研究
- Nashville, TN13 项研究
Durham的其他研究
- 乳腺癌64 项研究
- 癌症（所有类型）58 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 急性髓系白血病33 项研究
- 转移性癌症33 项研究
- 前列腺癌32 项研究
- 肺癌32 项研究
- 结直肠癌28 项研究
- 卵巢癌27 项研究
- 慢性淋巴细胞白血病27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。